{{Rsnum
|rsid=2648875
|Gene=PVT1
|Chromosome=8
|position=128059915
|Orientation=plus
|GMAF=0.4132
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PVT1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 36.3 | 53.1
| HCB | 35.0 | 41.6 | 23.4
| JPT | 36.6 | 54.5 | 8.9
| YRI | 26.0 | 48.6 | 25.3
| ASW | 12.3 | 56.1 | 31.6
| CHB | 35.0 | 41.6 | 23.4
| CHD | 41.7 | 43.5 | 14.8
| GIH | 26.7 | 47.5 | 25.7
| LWK | 27.3 | 55.5 | 17.3
| MEX | 27.6 | 44.8 | 27.6
| MKK | 21.8 | 42.3 | 35.9
| TSI | 2.0 | 34.3 | 63.7
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs2648875
|PubMedID=17395743
|Condition=End-stage renal disease
|Gene=PVT1
|Risk Allele=A
|pValue=2.00E-006
|OR=2.97
|95CI=1.90-4.65
}}

{{PharmGKB
|RSID=rs2648875
|Name_s=
|Gene_s=PVT1
|Feature=
|Evidence=PubMed ID:17395743; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study (Initial Sample Size: 105 cases, 102 controls; Replication Sample Size: NR; Risk Allele: rs2648875-A).
|Drugs=
|Drug Classes=
|Diseases=Kidney Failure, Chronic
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356601
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2648875
|overall_frequency_n=46
|overall_frequency_d=128
|overall_frequency=0.359375
|n_genomes=34
|n_genomes_annotated=0
|n_haplomes=46
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}